The ZYCOV-D vaccine candidate was developed by Cadila Healthcare Ltd. based in India[A219758]. The vaccine was developed using a DNA vaccine platform with a non-replicating and non-integrating plasmid carrying the gene of interest[L16503]. Once the plasmid D…